Cancer Institute A national cancer institute
designated cancer center

Jeffrey Axelrod

Publication Details

  • UNIQUE CYTOCHALASIN-B BINDING CHARACTERISTICS OF THE HEPATIC GLUCOSE CARRIER BIOCHEMISTRY Axelrod, J. D., Pilch, P. F. 1983; 22 (9): 2222-2227

    Abstract:

    Cytochalasin B is shown to inhibit uptake of 3-O-methylglucose into isolated rat hepatocytes with a Ki = 1.9 microM. The nature of this inhibition was characterized by studies of [3H]cytochalasin B binding to liver plasma membranes. Scatchard analysis of [3H]cytochalasin B binding reveals a complex curvilinear binding pattern. This pattern can be resolved into three components: (1) a high-affinity (ca. 10(-8) M) cytochalasin E sensitive site unrelated to glucose uptake, (2) a glucose-sensitive site, and (3) a low-affinity site. When 5 microM cytochalasin E is employed to mask the high-affinity site, glucose displaces 40-60% of the remaining [3H]cytochalasin B binding. Analysis of this glucose-sensitive cytochalasin B binding according to Scatchard reveals a Kd = 1.7 microM, indistinguishable from the concentration of cytochalasin B which half-maximally inhibits hepatic glucose uptake. These data identify a glucose-sensitive cytochalasin B binding site in liver plasma membranes which corresponds to the glucose carrier in the intact hepatocyte. The Ki of 1.9 microM for inhibition of hepatic glucose uptake by cytochalasin B and the Kd of 1.7 microM for [3H]cytochalasin B binding to liver plasma membranes are values 1 order of magnitude higher than values for the same parameters determined in all previous studies of facilitated hexose diffusion systems. The hepatic hexose carrier is therefore unique, and this uniqueness may be of regulatory significance with regard to glucose homeostasis.

    View details for Web of Science ID A1983QM57500025

    View details for PubMedID 6683102

Stanford Medicine Resources:

Footer Links: